Business Description
Navco Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA63942R1091
Share Class Description:
TSXV:NAV: Ordinary SharesCompare
Compare
Traded in other countries / regions
NAV.CanadaF0U.Germany IPO Date
2018-11-05Description
Navco Pharmaceuticals Inc uses nanotechnology to develop and commercialize novel products to protect against viruses, bacteria, and infectious diseases. Its products have applications in the medical, personal care products, textile, chemical, and additive industries which are tailored to defend against microorganisms such as viruses, bacteria, fungi, and infectious diseases.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | N/A |
N/A
|
N/A
| |||
| Equity-to-Asset | 0.04 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.07 | |||||
| 9-Day RSI | 40.86 | |||||
| 14-Day RSI | 42.85 | |||||
| 6-1 Month Momentum % | -50 | |||||
| 12-1 Month Momentum % | -20 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.04 | |||||
| Quick Ratio | 1.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -427.27 | |||||
| ROA % | -44.68 | |||||
| ROIC % | -294.44 | |||||
| ROCE % | -473.21 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
| EV-to-EBIT | -14.15 | |||||
| EV-to-EBITDA | -14.15 | |||||
| EV-to-FCF | -34.09 | |||||
| Earnings Yield (Greenblatt) % | -7.07 | |||||
| FCF Yield % | -3.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Navco Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.02 | ||
| Beta | 1.46 | ||
| Volatility % | 226.64 | ||
| 14-Day RSI | 42.85 | ||
| 14-Day ATR (C$) | 0.002255 | ||
| 20-Day SMA (C$) | 0.017 | ||
| 12-1 Month Momentum % | -20 | ||
| 52-Week Range (C$) | 0.01 - 0.115 | ||
| Shares Outstanding (Mil) | 57.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Navco Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Navco Pharmaceuticals Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Navco Pharmaceuticals Inc Frequently Asked Questions
What is Navco Pharmaceuticals Inc(TSXV:NAV)'s stock price today?
The current price of TSXV:NAV is C$0.02. The 52 week high of TSXV:NAV is C$0.12 and 52 week low is C$0.01.
When is next earnings date of Navco Pharmaceuticals Inc(TSXV:NAV)?
The next earnings date of Navco Pharmaceuticals Inc(TSXV:NAV) is .
Does Navco Pharmaceuticals Inc(TSXV:NAV) pay dividends? If so, how much?
Navco Pharmaceuticals Inc(TSXV:NAV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers